Dollar, money

Medtech Powerhouse: Abbott to Acquire St. Jude for $25 Billion

By MedTech Intelligence Staff
Dollar, money

The union of the two companies creates a market opportunity of nearly $30 billion.

In a deal just announced, Abbott will be acquiring St. Jude Medical for $25 billion. The deal will create a medtech powerhouse in the cardiovascular and neuromodulation markets. St Jude currently holds top positions in heart failure, atrial fibrillation and cardiac rhythm management, while Abbott is top in coronary intervention and transcatheter mitral repair. The union of the two companies creates a market opportunity of nearly $30 billion.

“Bringing together these two great companies will create a premier medical device business and immediately advance Abbott’s strategic and competitive position,” said Miles D. White, chairman and CEO of Abbott in a news release. “The combined business will have a powerful pipeline ready to deliver next-generation medical technologies and offer improved efficiencies for health care systems around the world.”

The transaction has been approved by St. Jude and Abbott board of directors and is subject to approval of St. Jude’s shareholders. It is expected to close by Q4 2016.

“Today’s announcement is an exciting next chapter for St. Jude Medical, bringing together two industry leaders with a shared passion for innovation, culture and patients,” said Michael T. Rousseau, St. Jude Medical president and CEO. “Our combined scale will expand the global reach, competitiveness and impact of our medical device innovation for physicians and hospitals.


Related Articles

  • Veeva Logo

    Veeva Vault CRM for Medtech is a unified customer relationship management (CRM) and content management application built for medtech sales teams, key account managers and medical affairs professionals.

  • FFRangio System

    Medtronic will invest up to $75 million and immediately begin co-promotion of CathWorks’ FFRangio System for the noninvasive diagnosis of CAD in the U.S., Europe and Japan, where it is commercially available.

  • Sean Smith

    LinkedIn has become the go-to social media platform for professionals to build their personal brands, promote their expertise and grow their careers or businesses. Following are key content characteristics and strategies shared by the leading medtech voices on LinkedIn that…

  • Axendia 2023 Events Logo

    Share your research, experience and expertise with your peers at the upcoming Medtech Advanced Manufacturing Conference and Medtech Supply Chain Intelligence Summit. Call for abstracts is now open.

About The Author

MedTech Intelligence